NRXP
NRX Pharmaceuticals Inc
3.30$
+0.9%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 0.8% | 0.0% | 0.2% | 99.6% | 100.0% | 99.9% | 94.1% | 90.4% | 68.6% | |
| 0.6% | 0.0% | 0.0% | 63.2% | 84.3% | 77.7% | 62.8% | 39.5% | 60.2% | |
| 0.6% | 0.0% | 0.0% | 63.2% | 84.3% | 77.7% | 62.8% | 39.5% | 60.2% | |
| – | – | – | 28.3% | 0.0% | 0.0% | 0.1% | 0.0% | 1.2% | |
| – | – | – | 7.3% | – | 0.0% | -0.1% | – | – | |
| – | – | – | – | – | – | – | 0.0% | 13.8% | |
| – | – | – | – | – | – | – | – | 7.1% | |
| 0.1% | 1.8% | 8.0% | 1,588.3% | 36.4% | 71.3% | 260.4% | 736.1% | 223.0% | |
| 0.1% | 0.8% | 1.9% | 1,569.7% | 36.4% | 60.4% | 260.4% | 598.8% | 220.6% | |
| – | – | – | 8.5% | 1.6% | 29.8% | 125.2% | 42.9% | 2.4% | |
| 0.1% | 0.8% | 1.9% | 107.2% | 11.3% | 8.0% | 63.3% | 113.1% | 33.0% | |
| – | 1.0% | 6.1% | 90.9% | – | 10.9% | – | 137.3% | – | |
| 99.9% | 98.2% | 92.0% | -1,488.3% | 63.6% | 28.7% | -160.4% | -636.1% | -123.0% | |
| -0.2% | -0.1% | 1.2% | -3,066.3% | -559.9% | -863.8% | -3,460.7% | -7,621.8% | -2,368.7% | |
| 1.3% | 1.3% | 1.6% | 18.6% | 143.4% | 254.8% | 103.6% | 288.1% | 165.2% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.